Clinical Trials Directory

Trials / Completed

CompletedNCT01439529

ECG Optimization of CRT: Evaluation of Mid-term Response

Optimization of Response to Cardiac Resynchronization Therapy by Electrocardiogram: an Assessment of Medium-term Response

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

New simpler methods to optimize cardiac resynchronization therapy (CRT) are being evaluated, such as the use of the electrocardiogram. In this prospective, double-blind, study, the investigators will evaluate: Primary endpoint: To compare the clinical response to CRT in patients with the programming optimized by QRS versus the nominal suggested by the device. Secondary endpoints: 1. To compare cardiac remodeling in patients with the programming optimized by QRS versus the nominal suggested by the device. 2. To evaluate the degree of asynchrony in both groups (nominal versus optimization by QRS) with respect to the intrinsic rhythm. 3. To evaluate the echocardiographic improvement in left ventricular (LV) filling in both groups. 4. To evaluate the differences in the optimal atrioventricular (AV) delay with atrial sensing or atrial pacing. For that, 180 patients with an indication for CRT will be randomized to nominal programming of the device or optimization by the electrocardiogram for a narrower QRS. A clinical and echocardiographic evaluation will be done at baseline, 6 and 12 months.

Conditions

Interventions

TypeNameDescription
OTHERDevice programming: nominalCRT device is programmed to nominal values
OTHERProgramming optimization by QRSCRT device is programmed by QRS optimization

Timeline

Start date
2009-04-01
Primary completion
2016-09-01
Completion
2017-09-01
First posted
2011-09-23
Last updated
2018-08-02

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01439529. Inclusion in this directory is not an endorsement.